News

Devdiscourse4h
AI-powered models slash time and cost in vaccine development
AI also supports reverse vaccinology, where pathogen genomes are computationally analyzed to identify immunogenic regions ...
Pharmabiz11h
SK bioscience seeks Korean regulatory approval to initiate phase 1/2 trial of adjuvanted influenza vaccine candidate, NBP607B
Seongnam, South Korea Saturday, July 19, 2025, 12:00 Hrs [IST] ...
Open Heart17h
‘Vaccination’ against myocardial infarction: the hidden long-term effect of coronary artery bypass grafting
In the field of invasive treatment of coronary artery disease (CAD), the past two decades have been characterised by the ...